NCT04867707View on ClinicalTrials.gov

Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 14, 2021

Primary Completion Date

October 18, 2024

Study Completion Date

October 18, 2024

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Zanamivir

5 days of treatment with 10mg zanamivir inhaler BID

Trial Locations (1)

65212

University of Missouri, School of Medicine Clinical Research Center, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER